We have over 40 years of combined team experience in pharmaceutical and healthcare marketing and consulting.

We offer services in the following areas:

• 1. Market analysis in multiple therapeutic areas
• 2. KOLs (Clinicians) interviews/perception studies
• 3. Patient flow analysis or Patient tracking
• 4. Competitor/Company profiling
• 5. KOLs/Clinician profiling
• 6. Sales force deployment tracking

Some of our case studies:

1. Market potential of a novel product under clinical stage of development

Our client was a US based specialty pharmaceutical company who is developing first-in class product with novel mechanism of action for treating a rare disease. Healthbeats Consulting through research based analysis helped the client in understanding the market scenario including competitor landscaping (current and future), place in therapy (therapeutic guideline analysis, clinical efficacy and safety comparative analysis) and the preliminary market potential (sales forecast) for their product through secondary research based market intelligence analysis.

2. Primary research case study

Healthbeats Consulting helped a large multinational pharmaceutical company in identifying generic threat from Indian generic pharmaceutical companies for its late life cycle product through primary research based competitive intelligence.

3. Hidradenitis suppurativa case study

Hidradenitis suppurativa (Acne vulgaris) USA market overview for a novel therapeutic agent under phase II clinical development

Client: A large size pharmaceutical company
Objective: The client has a novel therapeutic agent under phase II development for the treatment of autoimmune dermatology disorder “Acne vulgaris”. Currently the client wanted a comprehensive market understanding of the US market.
Process: In order to give the client a through market understanding we conducted a therapeutic area analysis combined with secondary research based market intelligence covering competition analysis (current and new product pipeline), treatment guideline analysis, epidemiology, market size, clinical trial analysis (efficacy and safety analysis).
Based on the outcome of the market analysis we evaluated the key unmet needs, market size of US market (both number of patients and value market size), treatment algorithm, competitive landscape, patient journey, place in therapy for the client’s product.
Outcome: The client received a detailed set of market analysis for the US market which enabled the client to have a better understanding of the market, identify market risks and evaluate market potential for their product.

4. Blockbuster anti-diabetic product case study

Competitive scenario for a blockbuster anti-diabetic product pre and post loss of exclusivity (LoE)

Client: A large size pharmaceutical company
Objective: The client has a blockbuster anti-diabetic product which is expected to lose exclusivity in a couple of years. The client as part of their lifecycle management strategy wanted to understand the competitive threats post LoE and related generic development happening currently in India.
Process: We conducted a competitive intelligence analysis supported with both primary and second research competition mapping, identifying generic product pipeline with timelines, identifying API sources involved in generic development, product capacity of competitors, expected ex-factory price, marketing and sales strategies.
Based on the outcome of the market analysis we created a SWOT analysis of each of the competitors, generic threat analysis from India and a timeline of generic introduction.
Outcome: The client received a detailed set of competitive intelligence analysis for the generic threat emerging out of India which enabled the client to have a better understanding of the pre and post LoE threats for strengthening their lifecycle management staregies.